ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 16 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $131,000 | +5.6% | 140,000 | 0.0% | 0.00% | – |
| Q3 2014 | $124,000 | -87.9% | 140,000 | -86.0% | 0.00% | – |
| Q1 2014 | $1,029,000 | -65.1% | 1,000,000 | -64.8% | 0.00% | -100.0% |
| Q4 2013 | $2,947,000 | -48.7% | 2,837,000 | -43.3% | 0.00% | -50.0% |
| Q3 2013 | $5,741,000 | -14.9% | 5,000,000 | -29.4% | 0.00% | -33.3% |
| Q2 2013 | $6,744,000 | – | 7,085,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 16,800,000 | $22,837,000 | 2.09% |
| Redmile Group, LLC | 19,000,000 | $25,656,000 | 1.56% |
| CSS LLC/IL | 17,405,000 | $23,518,000 | 1.14% |
| LINDEN ADVISORS LP | 16,335,000 | $22,249,000 | 0.94% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,715,000 | $28,081,000 | 0.36% |
| Fernwood Investment Management, LLC | 90,000 | $122,000 | 0.09% |
| Baker Brothers Advisors | 3,000,000 | $4,066,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 13,500,000 | $18,385,000 | 0.04% |
| Citadel Advisors | 22,070,000 | $29,896,000 | 0.02% |
| GABELLI FUNDS LLC | 1,501,000 | $2,037,000 | 0.01% |